Is pre‐operative radiotherapy necessary in T1‐T3 rectal cancer with TME?

Publisher Website
Google Scholar
Abstract
Objective  The indications for pre‐operative radiotherapy in rectal cancer are still unclear with the exception of T4 tumours. The aim of this study was to assess local and overall recurrence in patients with T1‐T3 rectal cancers undergoing total mesorectal excision (TME).Methods  Prospective data was collected from 150 patients with rectal cancer treated in one surgical centre between July 1997 and July 2002. One hundred and twenty‐nine primary resections were carried of which 102 were with curative intent. Seventy‐nine patients with T1‐T3 tumours were included in the analysis. Nine had local resections and 70 underwent TME; 19 of the 70 patients were node positive and 51 were node negative.Results  At a median follow‐up of 37 months (range 19–79 months) there were 3 (4.3%) isolated local recurrences. One node positive patient developed isolated local recurrence compared with 2 node negative patients. The node positive patient died from a myocardial infarction while the two node negative patients died as a consequence of local recurrence. Three (4.3%) of 70 patients developed systemic relapse all of whom were node positive. The cancer specific mortality rate over the same follow‐up period was 3/19 for node positive patients and 2/51 for node negative patients. Of 9 patients who had local resections, none developed local recurrence or systemic relapse.Conclusions  With TME the rate of local recurrence in T1‐T3 tumours is low. Our results do not support the use of pre‐operative radiotherapy for these patients.